Merck’s COVID-19 pill active against Omicron in lab studies
Summary : Merck & Co Inc and partner Ridgeback Biotherapeutics said on Friday six lab studies showed their experimental oral COVID-19 drug molnupiravir…
Summary : Merck & Co Inc and partner Ridgeback Biotherapeutics said on Friday six lab studies showed their experimental oral COVID-19 drug molnupiravir…
Synopsis : Natco Pharma Limited and Biophore India Pharmaceuticals have received the license from the Medicines Patent Pool (MPP), Switzerland, to manufacture and…
Synopsis : – Sun Pharmaceutical Industries Limited announced that one of its wholly owned subsidiaries has received Emergency Use Authorization (EUA) from…
Synopsis: Torrent Pharma announced that it is introducing MSD (a trade name of Merck & Co., Inc, Kenilworth, New Jersey, USA) and…
KEYPOINTS: The UK became the first country to approve Covid-19 antiviral pill, jointly developed by US-based Merck & Co Inc and Ridgeback…
Key points: India’s Everest Organics starts manufacturing Molnupiravir Active Pharmaceutical ingredient (API) for Merck’s COVID-19 pill. Everything you need to know about…
Pharma Majors Collaborate for Clinical Trial of Investigational Oral Anti-Viral Drug Molnupiravir for COVID-19 Cipla, Dr. Reddy’s, Emcure, Sun Pharma and Torrent…